Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2

Vivek K Gupta1, Madhan K Murthy2, Shripad Patil2

  • 1Department of Biochemistry, ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra-282004, India.

Current Drug Targets
|November 27, 2020
PubMed

Insights

This review explores how host cell proteases, such as ACE2, ADAM17, and TMPRSS2, and the androgen receptor (AR) facilitate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry and infection. Inhibiting these proteins may offer a therapeutic strategy against SARS-CoV-2.

Area of Science:

  • Virology
  • Molecular Biology
  • Pathophysiology

Background:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a global pandemic.
  • Viral entry into host cells is a critical step for infection, involving virus-host protein interactions.
  • Host cell proteases and androgen receptor are implicated in SARS-CoV-2 pathogenesis.

Purpose of the Study:

  • To review the role of host cell proteases (ACE2, ADAM17, TMPRSS2) and androgen receptor (AR) in SARS-CoV-2 infection.
  • To elucidate how these host factors contribute to viral spread and disease severity.
  • To explore the potential of inhibiting these host proteins as a therapeutic approach.

Main Methods:

  • Literature review of published articles, including reviews, research papers, preprints, and official documents.
  • Analysis of physiological aspects relevant to SARS-CoV and SARS-CoV-2.
  • Synthesis of existing data to hypothesize the roles of specific host proteins.

Main Results:

  • ACE2, ADAM17, and TMPRSS2 are key proteases involved in SARS-CoV-2 entry.
  • Androgen receptor (AR) also plays a significant role in SARS-CoV-2 infection.
  • These host proteins enhance viral pathology and infectivity.

Conclusions:

  • Host cell proteases and androgen receptor are crucial for SARS-CoV-2 infection.
  • Targeting these host proteins presents a potential therapeutic avenue for preventing or treating SARS-CoV-2 infections.
  • Further research into these host-pathogen interactions is warranted.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
24.4K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.5K